Search

Author/Creator Sherman, M.

1. 53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY. (April 2015)

Authors:
Platzbecker, U.; Germing, U.; Giagounidis, A.; Götze, K.; Kiewe, P.; Mayer, K.; Ottmann, O.; Radsak, M.; Wolff, T.; Haase, D.; Hankin, M.; Wilson, D.; Zhang, X.; Laadem, A.; Sherman, M.; Attie, K.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Historical epidemiology of hepatitis C virus (HCV) in selected countries. (May 2014)

Authors:
Bruggmann, P.; Berg, T.; Øvrehus, A. L. H.; Moreno, C.; Brandão Mello, C. E.; Roudot‐Thoraval, F.; Marinho, R. T.; Sherman, M.; Ryder, S. D.; Sperl, J.; Akarca, U.; Balık, İ.; Bihl, F.; Bilodeau, M.; Blasco, A. J.; Buti, M.; Calinas, F.; Calleja, J. L.; Cheinquer, H.; Christensen, P. B.
Journal:
Journal of viral hepatitis
Issue:
Volume 21(2014)Supplement 1
Page Start:
5
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection. (September 2020)

Authors:
Ben-Ami, R.; Klochendler, A.; Seidel, M.; Sido, T.; Gurel-Gurevich, O.; Yassour, M.; Meshorer, E.; Benedek, G.; Fogel, I.; Oiknine-Djian, E.; Gertler, A.; Rotstein, Z.; Lavi, B.; Dor, Y.; Wolf, D.G.; Salton, M.; Drier, Y.; Klochendler, A.; Eden, A.; Klar, A.
Journal:
Clinical microbiology and infection
Issue:
Volume 26:Number 9(2020)
Page Start:
1248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Luspatercept Response in New Subpopulations of Patients with Lower-Risk Myelodysplastic Syndromes (MDS): Update of the Pace Study. (April 2017)

Authors:
Platzbecker, U.; Germing, U.; Götze, K.; Kiewe, P.; Wolff, T.; Mayer, K.; Chromik, J.; Radsak, M.; Wilson, D.; Zhang, X.; Laadem, A.; Sherman, M.; Attie, K.; Linde, P.; Giagounidis, A.
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Strategies to manage hepatitis C virus (HCV) disease burden. (May 2014)

Authors:
Wedemeyer, H.; Duberg, A. S.; Buti, M.; Rosenberg, W. M.; Frankova, S.; Esmat, G.; Örmeci, N.; Van Vlierberghe, H.; Gschwantler, M.; Akarca, U.; Aleman, S.; Balık, İ.; Berg, T.; Bihl, F.; Bilodeau, M.; Blasco, A. J.; Brandão Mello, C. E.; Bruggmann, P.; Calinas, F.; Calleja, J. L.
Journal:
Journal of viral hepatitis
Issue:
Volume 21(2014)Supplement 1
Page Start:
60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. (May 2014)

Authors:
Razavi, H.; Waked, I.; Sarrazin, C.; Myers, R. P.; Idilman, R.; Calinas, F.; Vogel, W.; Mendes Correa, M. C.; Hézode, C.; Lázaro, P.; Akarca, U.; Aleman, S.; Balık, İ.; Berg, T.; Bihl, F.; Bilodeau, M.; Blasco, A. J.; Brandão Mello, C. E.; Bruggmann, P.; Buti, M.
Journal:
Journal of viral hepatitis
Issue:
Volume 21(2014)Supplement 1
Page Start:
34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗